shutterstock-237137014-web

Germany's Federal Court of Justice - wingrim / Shutterstock.com

20 September 2016EuropeBernd Allekotte and Markus Grammel

Mind your language

The German Federal Court of Justice (FCJ) considered the infringement of a Swiss-type medical use claim under the doctrine of equivalents for the first time in the June decision of X ZR 29/15 (Pemetrexed).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Lord Justice Birss to become chancellor of the High Court

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

Broad Institute wins appeal to restore CRISPR patent in Europe

AstraZeneca forced to clarify deal terms in row with university

UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung